81 related articles for article (PubMed ID: 21178652)
1. Calcitonin-secreting pancreatic endocrine tumors: systematic analysis of a rare tumor entity.
Schneider R; Waldmann J; Swaid Z; Ramaswamy A; Fendrich V; Bartsch DK; Schlosser K
Pancreas; 2011 Mar; 40(2):213-21. PubMed ID: 21178652
[TBL] [Abstract][Full Text] [Related]
2. Differentiation between thyroidal and ectopic calcitonin secretion in patients with coincidental thyroid nodules and pancreatic tumors - a report of two cases.
Schneider R; Heverhagen AE; Moll R; Bartsch DK; Schlosser K
Exp Clin Endocrinol Diabetes; 2010 Aug; 118(8):520-3. PubMed ID: 19691012
[TBL] [Abstract][Full Text] [Related]
3. VIPomas: an update in diagnosis and management in a series of 11 patients.
Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Safioleas M; Mallas E; Polyzos A
Hepatogastroenterology; 2005; 52(64):1259-65. PubMed ID: 16001675
[TBL] [Abstract][Full Text] [Related]
4. Calcitonin-secreting tumor of the pancreas.
Mullerpatan PM; Joshi SR; Shah RC; Tampi CS; Doctor VM; Jagannath P; Modlin I
Dig Surg; 2004; 21(4):321-4. PubMed ID: 15375334
[TBL] [Abstract][Full Text] [Related]
5. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
6. A calcitonin and vasoactive intestinal peptide-producing pancreatic endocrine tumor associated with the WDHA syndrome.
Ichimura T; Kondo S; Okushiba S; Morikawa T; Katoh H
Int J Gastrointest Cancer; 2003; 33(2-3):99-102. PubMed ID: 14716055
[TBL] [Abstract][Full Text] [Related]
7. Asymptomatic calcitonin-secreting tumor of the pancreas. A case report.
Delis S; Bakoyiannis A; Giannakou N; Tsigka A; Avgerinos C; Dervenis C
JOP; 2006 Jan; 7(1):70-3. PubMed ID: 16407623
[TBL] [Abstract][Full Text] [Related]
8. VIP and calcitonin-producing pancreatic neuroendocrine tumor with watery diarrhea: clinicopathological features and the effect of somatostatin analogue.
Kon T; Wada R; Suzuki R; Nakayama Y; Ebina Y; Yagihashi S
JOP; 2012 Mar; 13(2):226-30. PubMed ID: 22406608
[TBL] [Abstract][Full Text] [Related]
9. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cystic endocrine tumors: a different morphological entity associated with a less aggressive behavior.
Boninsegna L; Partelli S; D'Innocenzio MM; Capelli P; Scarpa A; Bassi C; Pederzoli P; Falconi M
Neuroendocrinology; 2010; 92(4):246-51. PubMed ID: 20689265
[TBL] [Abstract][Full Text] [Related]
11. Large cell carcinoma with calcitonin and vasoactive intestinal polypeptide-associated Verner-Morrison syndrome.
Pratz KW; Ma C; Aubry MC; Vrtiska TJ; Erlichman C
Mayo Clin Proc; 2005 Jan; 80(1):116-20. PubMed ID: 15667039
[TBL] [Abstract][Full Text] [Related]
12. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
[TBL] [Abstract][Full Text] [Related]
13. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
[TBL] [Abstract][Full Text] [Related]
14. Digestive calcitonin-secreting tumors of the foregut: comparison with non-calcitonin-secreting tumors.
Wuilmet L; Jovenin N; Larbre H; Lévy-Bohbot N; Diebold MD; Jolly D; Delemer B; Thiéfin G; Cadiot G
Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):951-5. PubMed ID: 16894307
[TBL] [Abstract][Full Text] [Related]
15. Neuroendocrine tumors producing calcitonin: characteristics, prognosis and potential interest of calcitonin monitoring during follow-up.
Nozières C; Chardon L; Goichot B; Borson-Chazot F; Hervieu V; Chikh K; Lombard-Bohas C; Walter T
Eur J Endocrinol; 2016 Mar; 174(3):335-41. PubMed ID: 26671974
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity in pancreatic endocrine tumors.
Tang SJ; Dumot JA; Wang L; Memmesheimer C; Conwell DL; Zuccaro G; Goormastic M; Ormsby AH; Cowell J
Am J Gastroenterol; 2002 Apr; 97(4):1022-30. PubMed ID: 12003383
[TBL] [Abstract][Full Text] [Related]
17. An aggressive surgical approach leads to long-term survival in patients with pancreatic endocrine tumors.
Fendrich V; Langer P; Celik I; Bartsch DK; Zielke A; Ramaswamy A; Rothmund M
Ann Surg; 2006 Dec; 244(6):845-51; discussion 852-3. PubMed ID: 17122609
[TBL] [Abstract][Full Text] [Related]
18. Central pancreatectomy: single-center experience of 50 cases.
Adham M; Giunippero A; Hervieu V; Courbière M; Partensky C
Arch Surg; 2008 Feb; 143(2):175-80; discussion 180-1. PubMed ID: 18283143
[TBL] [Abstract][Full Text] [Related]
19. Multimodality management of a polyfunctional pancreatic endocrine carcinoma with markedly elevated serum vasoactive intestinal polypeptide and calcitonin levels.
Nasir A; Gardner NM; Strosberg J; Ahmad N; Choi J; Malafa MP; Coppola D; Kwekkeboom DJ; Teunissen JJ; Kvols LK
Pancreas; 2008 Apr; 36(3):309-13. PubMed ID: 18362846
[TBL] [Abstract][Full Text] [Related]
20. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
Kazanjian KK; Reber HA; Hines OJ
Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]